Literature DB >> 20361358

Quantitative assessment of visceral fat in morbidly obese patients by means of wide-bore MRI and its relation to lower esophageal sphincter pressure and signs of gastroesophageal reflux.

Fabian Springer1, Manuel Schwarz, Jürgen Machann, Andreas Fritsche, Claus D Claussen, Fritz Schick, Joachim H Schneider.   

Abstract

BACKGROUND: The aim of this study was to quantitatively assess visceral adipose tissue (VAT) by means of a wide-bore MR scanner in a cohort of morbidly obese patients referred for bariatric surgery. Furthermore, it was investigated whether gastroesophageal reflux disease (GERD) and lower esophageal sphincter pressure (LESP) are related to the volume of visceral fat masses.
METHODS: Twenty-five morbidly obese patients (nine male, 16 female) were prospectively enrolled. In addition to common anthropometric measures of obesity, VAT was determined quantitatively by multi-slice MRI. Symptoms of GERD were evaluated using a standardized questionnaire, while endoscopy of the upper gastrointestinal tract was performed to reveal pathologies of the gastroesophageal junction. LESP was evaluated by esophageal manometry.
RESULTS: Study population showed a body mass index (BMI) between 35.2 and 59.1 kg/m(2). Waist-to-hip ratio and VAT were significantly higher (p < 0.0001; p = 0.0021) in males (1.05 +/- 0.05; 8.89 +/- 2.33 l) than in females (0.86 +/- 0.07; 6.04 +/- 1.28 l). VAT was not correlated to BMI. LESP values and GERD-related symptoms were neither dependent on anthropometric measures nor on VAT in our cohort.
CONCLUSIONS: VAT did not show a positive correlation with BMI in our cohort of extremely obese subjects, indicating a pronounced fat deposition in subcutaneous tissue compartment. Moreover, this indicates that VAT is limited to a gender-dependent maximum volume for each individual and seems to be no further increasing in extremely obese subjects. This might be the reason that neither symptoms nor endoscopic findings of GERD nor LESP were significantly influenced by the stage of morbid obesity.

Entities:  

Mesh:

Year:  2010        PMID: 20361358     DOI: 10.1007/s11695-010-0119-x

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  33 in total

Review 1.  Gastro-oesophageal reflux disease.

Authors:  Paul Moayyedi; Nicholas J Talley
Journal:  Lancet       Date:  2006-06-24       Impact factor: 79.321

Review 2.  The association between gastroesophageal reflux disease and obesity.

Authors:  Frank K Friedenberg; Melissa Xanthopoulos; Gary D Foster; Joel E Richter
Journal:  Am J Gastroenterol       Date:  2008-08       Impact factor: 10.864

3.  Age and gender related effects on adipose tissue compartments of subjects with increased risk for type 2 diabetes: a whole body MRI/MRS study.

Authors:  J Machann; C Thamer; B Schnoedt; N Stefan; M Stumvoll; H-U Haring; C D Claussen; A Fritsche; F Schick
Journal:  MAGMA       Date:  2005-07-06       Impact factor: 2.310

4.  Obesity correlates with gastroesophageal reflux.

Authors:  B L Fisher; A Pennathur; J L Mutnick; A G Little
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

Review 5.  Rationale and efficacy of conservative therapy for gastroesophageal reflux disease.

Authors:  L I Kitchin; D O Castell
Journal:  Arch Intern Med       Date:  1991-03

6.  Association of obesity with hiatal hernia and esophagitis.

Authors:  L J Wilson; W Ma; B I Hirschowitz
Journal:  Am J Gastroenterol       Date:  1999-10       Impact factor: 10.864

7.  Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups.

Authors:  S J Chung; D Kim; M J Park; Y S Kim; J S Kim; H C Jung; I S Song
Journal:  Gut       Date:  2008-04-25       Impact factor: 23.059

8.  Transient lower esophageal sphincter relaxation in morbid obesity.

Authors:  J H Schneider; M Küper; A Königsrainer; B Brücher
Journal:  Obes Surg       Date:  2009-02-18       Impact factor: 4.129

9.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus.

Authors:  Douglas A Corley; Ai Kubo; Theodore R Levin; Gladys Block; Laurel Habel; Wei Zhao; Pat Leighton; Charles Quesenberry; Greg J Rumore; Patricia A Buffler
Journal:  Gastroenterology       Date:  2007-04-25       Impact factor: 22.682

10.  Gastroesophageal reflux disease and obesity. Pathophysiology and implications for treatment.

Authors:  Fernando A M Herbella; Matthew P Sweet; Pietro Tedesco; Ian Nipomnick; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.267

View more
  2 in total

1.  Lack of correlation between morbid obesity and severe gastroesophageal reflux disease in candidates for bariatric surgery: results of a large prospective study.

Authors:  Alberto Zalar; Baya Haddouche; Michel Antonietti; Raied Alhameedi; Isabelle Iwanicki-Caron; Stéphane Lecleire; Philippe Ducrotté
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

2.  Role of body composition and metabolic profile in Barrett's oesophagus and progression to cancer.

Authors:  Simona Di Caro; Wui Hang Cheung; Lucia Fini; Margaret G Keane; Belinda Theis; Rehan Haidry; Laura Di Renzo; Antonino De Lorenzo; Laurence Lovat; Rachel L Batterham; Matthew Banks
Journal:  Eur J Gastroenterol Hepatol       Date:  2016-03       Impact factor: 2.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.